The impact of astrocytic NF-κB on healthy and Alzheimer's disease brains

Tee Jong Huat,Judith Camats-Perna,Estella A. Newcombe,Tessa Onraet,Daniel Campbell,Josiah T. Sucic,Alessandra Martini,Stefânia Forner,Mehdi Mirzaei,Wayne Poon,Frank M. LaFerla,Rodrigo Medeiros

DOI: https://doi.org/10.1038/s41598-024-65248-1

IF: 4.6

2024-06-23

Scientific Reports

Abstract:Astrocytes play a role in healthy cognitive function and Alzheimer's disease (AD). The transcriptional factor nuclear factor-κB (NF-κB) drives astrocyte diversity, but the mechanisms are not fully understood. By combining studies in human brains and animal models and selectively manipulating NF-κB function in astrocytes, we deepened the understanding of the role of astrocytic NF-κB in brain health and AD. In silico analysis of bulk and cell-specific transcriptomic data revealed the association of NF-κB and astrocytes in AD. Confocal studies validated the higher level of p50 NF-κB and phosphorylated-p65 NF-κB in glial fibrillary acidic protein (GFAP) + -astrocytes in AD versus non-AD subjects. In the healthy mouse brain, chronic activation of astrocytic NF-κB disturbed the proteomic milieu, causing a loss of mitochondrial-associated proteins and the rise of inflammatory-related proteins. Sustained NF-κB signaling also led to microglial reactivity, production of pro-inflammatory mediators, and buildup of senescence-related protein p16 INK4A in neurons. However, in an AD mouse model, NF-κB inhibition accelerated β-amyloid and tau accumulation. Molecular biology studies revealed that astrocytic NF-κB activation drives the increase in GFAP and inflammatory proteins and aquaporin-4, a glymphatic system protein that assists in mitigating AD. Our investigation uncovered fundamental mechanisms by which NF-κB enables astrocytes' neuroprotective and neurotoxic responses in the brain.

multidisciplinary sciences

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on understanding the mechanism of nuclear factor - κB (NF - κB) in astrocytes in healthy brains and Alzheimer's disease (AD) brains. Specifically, by combining research on human brains and animal models and selectively manipulating the NF - κB function in astrocytes, the researchers delved into the role of NF - κB in brain health and AD. The following are the main research questions of the paper: 1. **The association between NF - κB and astrocytes in AD**: - By analyzing bulk and cell - specific transcriptome data, the researchers revealed the association between NF - κB and astrocytes in AD. Specifically, it is manifested as the increase in the levels of p50 NF - κB and phosphorylated p65 NF - κB in GFAP - positive astrocytes in the brains of AD patients. 2. **The impact of chronic activation of NF - κB on healthy brains**: - In the healthy mouse brains, chronic activation of NF - κB in astrocytes will disrupt the protein environment, leading to a decrease in mitochondrial - related proteins and an increase in inflammation - related proteins. Continuous NF - κB signaling will also trigger microglial cell responses, the production of pro - inflammatory mediators, and the accumulation of the senescence - related protein p16INK4A in neurons. 3. **The impact of NF - κB inhibition on AD model mice**: - In AD model mice, the inhibition of NF - κB accelerates the accumulation of β - amyloid (Aβ) and tau proteins. Molecular biology studies have shown that the activation of NF - κB in astrocytes drives the increase in GFAP and inflammatory proteins, as well as the increase in the glymphatic system protein aquaporin - 4 (AQP4) in the brain, which helps to alleviate AD. 4. **The dual role of NF - κB in astrocytes**: - The research has revealed the neuroprotective and neurotoxic response mechanisms of NF - κB in astrocytes. NF - κB is not only involved in clearing excessive neurotransmitters and toxic Aβ and tau proteins, but also regulates efficient inter - cellular communication, enabling cells to respond appropriately to changes in the microenvironment. In summary, this paper aims to comprehensively analyze the complex role of NF - κB in astrocytes, especially the mechanism in the AD pathological process, providing a theoretical basis for further understanding the pathogenesis of AD and potential treatment strategies.

The impact of astrocytic NF-κB on healthy and Alzheimer's disease brains

NFκB-activated astroglial release of complement C3 compromises neuronal morphology and function associated with Alzheimer's disease.

Signaling pathways regulating neuron-glia interaction and their implications in Alzheimer's disease.

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

IκBα Deficiency in Brain Leads to Elevated Basal Neuroinflammation and Attenuated Response Following Traumatic Brain Injury: Implications for Functional Recovery

Signaling Pathways Regulating Neuron–glia Interaction and Their Implications in Alzheimer's Disease

Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimer'S Disease

Astroglial NF-kB contributes to white matter damage and cognitive impairment in a mouse model of vascular dementia

Single-nucleus transcriptional profiling uncovers the reprogrammed metabolism of astrocytes in Alzheimer's disease.

The Difference in Gliosis Induced by Β-Amyloid and Tau Treatments in Astrocyte Cultures Derived from Senescence Accelerated and Normal Mouse Strains

Involvement of Astrocytes in Alzheimer's Disease from a Neuroinflammatory and Oxidative Stress Perspective

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Systematic review of human post-mortem immunohistochemical studies and bioinformatics analyses unveil the complexity of astrocyte reaction in Alzheimer's disease

Upstream Regulators and Downstream Effectors of Nf-Kappa B in Alzheimer'S Disease

Astrocytic AT1R deficiency ameliorates Aβ-induced cognitive deficits and synaptotoxicity through β-arrestin2 signaling

Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.

Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology

Astrocytes as Neuroimmunocytes in Alzheimer's Disease: A Biochemical Tool in the Neuron-Glia Crosstalk along the Pathogenetic Pathways

NF-kappaB mediates IL-1beta-induced synthesis/release of alpha2-macroglobulin in a human glial cell line.

Activation of astrocytic NMDA receptors counteracted Aβ-induced reduction of BDNF and elevation of GFAP and complement 3 in the hippocampal astrocytes

Morphofunctional Investigation in a Transgenic Mouse Model of Alzheimer's Disease: Non-Reactive Astrocytes Are Involved in Aβ Load and Reactive Astrocytes in Plaque Build-Up